Literature DB >> 24078662

Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M Stahl1, C Mariette, K Haustermans, A Cervantes, D Arnold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24078662     DOI: 10.1093/annonc/mdt342

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  72 in total

1.  Different accuracy of endosonographic tumor staging after neoadjuvant chemotherapy and chemoradiotherapy in esophageal cancer.

Authors:  Wolfram Bohle; Michaela Kasper; Wolfram G Zoller
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

2.  Change in volume parameters induced by neoadjuvant chemotherapy provide accurate prediction of overall survival after resection in patients with oesophageal cancer.

Authors:  Dietmar Tamandl; Richard M Gore; Barbara Fueger; Patrick Kinsperger; Michael Hejna; Matthias Paireder; Alexander Haug; Sebastian F Schoppmann; Ahmed Ba-Ssalamah
Journal:  Eur Radiol       Date:  2015-06-05       Impact factor: 5.315

3.  Argon plasma coagulation compared with stent placement in the palliative treatment of inoperable oesophageal cancer.

Authors:  Dimitrios E Sigounas; Christoforos Krystallis; Graeme Couper; Simon Paterson-Brown; Athina Tatsioni; John N Plevris
Journal:  United European Gastroenterol J       Date:  2016-06-23       Impact factor: 4.623

Review 4.  Gastric Preconditioning in Advance of Esophageal Resection-Systematic Review and Meta-Analysis.

Authors:  Patrick Heger; Susanne Blank; Markus K Diener; Alexis Ulrich; Thomas Schmidt; Markus W Büchler; André L Mihaljevic
Journal:  J Gastrointest Surg       Date:  2017-04-24       Impact factor: 3.452

5.  Feasibility of a novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancer.

Authors:  Steen Riisgaard de Blanck; Jonas Scherman-Rydhög; Mette Siemsen; Merete Christensen; Lene Baeksgaard; Rasmus Irming Jølck; Lena Specht; Thomas Lars Andresen; Gitte Fredberg Persson
Journal:  Br J Radiol       Date:  2018-07-09       Impact factor: 3.039

6.  The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort Study.

Authors:  George Papaxoinis; Konstantinos Kamposioras; Jamie M J Weaver; Zoe Kordatou; Sofia Stamatopoulou; Theodora Germetaki; Magdy Nasralla; Vikki Owen-Holt; Alan Anthoney; Wasat Mansoor
Journal:  J Gastrointest Surg       Date:  2019-01-22       Impact factor: 3.452

7.  Evaluation of the 7(th) edition of the UICC-AJCC tumor, node, metastasis classification for esophageal cancer in a Chinese cohort.

Authors:  Yan Huang; Weigang Guo; Shiming Shi; Jian He
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 8.  Operable gastro-oesophageal junctional adenocarcinoma: Where to next?

Authors:  Elizabeth C Smyth; David Cunningham
Journal:  World J Gastrointest Oncol       Date:  2014-06-15

Review 9.  Quality in upper gastrointestinal endoscopic submucosal dissection.

Authors:  Flaminia Purchiaroni; Guido Costamagna; Cesare Hassan
Journal:  Ann Transl Med       Date:  2018-07

Review 10.  Barrett's esophagus in 2016: From pathophysiology to treatment.

Authors:  Irene Martinucci; Nicola de Bortoli; Salvatore Russo; Lorenzo Bertani; Manuele Furnari; Anna Mokrowiecka; Ewa Malecka-Panas; Vincenzo Savarino; Edoardo Savarino; Santino Marchi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.